A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
Clinical trial NCT00416520 · COMPLETED
Trial details
- NCT number
- NCT00416520
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-11-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.